miR-139-5p Regulates the Proliferation of Acute Promyelocytic Leukemia Cells by Targeting MNT

Yueyue Fu1, Limin Li2, Jinxiao Hou1

  • 1Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, Heilongjiang, China.

Insights

MicroRNAs regulate white blood cell counts in acute promyelocytic leukemia (APL). Downregulated miR-139-5p is linked to leukocytosis, and restoring its levels may offer new APL treatment strategies.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Progressive leukocytosis in acute promyelocytic leukemia (APL) correlates with poor outcomes.
  • The specific microRNA (miRNA) roles in APL leukocytosis remain unclear.

Purpose of the Study:

  • To investigate the impact of miRNAs on leukocytosis during APL induction therapy.
  • To explore the underlying mechanisms of miRNA regulation in APL.

Main Methods:

  • Patients undergoing induction therapy were categorized into leukocytosis and non-leukocytosis groups based on white blood cell counts.
  • Microarray analysis was employed to identify differentially expressed miRNAs.
  • In vitro studies using NB4 cells assessed the functional effects of miR-139-5p and its target MNT.

Main Results:

  • miR-139-5p was significantly downregulated in APL patients with leukocytosis.
  • Increased miR-139-5p expression suppressed NB4 cell proliferation via cell cycle arrest and apoptosis induction.
  • MNT was identified as a direct target of miR-139-5p, mediating its effects on cell proliferation, invasion, and migration.

Conclusions:

  • miR-139-5p plays a crucial role in controlling leukocytosis in APL.
  • Targeting miR-139-5p or its downstream effector MNT presents a potential therapeutic avenue for managing progressive leukocytosis in APL.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K